Chiron, Affymetrix up on 3Q EPS

Both CHIR and AFFX were trading up after announcing after market close Wednesday beating and meeting their EPS estimates, respectively. AFFX was up $6.03 (28%) to $27.56 on Thursday after reporting a third quarter loss of $0.11, in line with consensus estimates. The market appeared to be impressed that revenues, which consist primarily of sales of its GeneChip microarrays, came in at $55.4 million -- above the $52 million Street estimate (see BioCentury Extra, Wednesday Oct. 24). Also on Thursday, AFFX settled its litigation with Hyseq (HYSQ) (see above). ...